Efficacy of Gastric Biopsy for Culture and Antibiotic Sensitivity Assessment
Launched by THE BARUCH PADEH MEDICAL CENTER, PORIYA · Aug 10, 2011
Trial Information
Current as of May 19, 2025
Withdrawn
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all referred for gastroscopy with clinical or endoscopic signs of peptic disease
- Exclusion Criteria:
- • coagulation disorders
- • pregnant women
About The Baruch Padeh Medical Center, Poriya
The Baruch Padeh Medical Center Poriya is a leading healthcare institution located in northern Israel, dedicated to providing high-quality medical services and advancing clinical research. As a prominent clinical trial sponsor, the center focuses on innovative therapeutic solutions across various medical disciplines, emphasizing patient-centered care and interdisciplinary collaboration. The facility is equipped with state-of-the-art technologies and a team of experienced professionals committed to enhancing medical knowledge and improving patient outcomes through rigorous clinical research and trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Maya PAritsky, MD
Principal Investigator
Baruch Padeh MC, Israel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials